Hemispherx Biopharma Inc (HEB) - Medical Equipment - Deals and Alliances Profile

Summary

Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the treatment of various diseases such as hepatitis B, hepatitis C, chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME), kidney cancer and metastatic malignant melanoma; multiple sclerosis, hepatitis C, HIV, west Nile virus, and SARS; and Alferon LDO (Low Dose Oral), an oral form of Alferon N Injection for influenza viruses. The company operates production facility in New Brunswick, New Jersey. Hemispherx is headquartered in Orlando, Florida, the US.

Hemispherx Biopharma Inc (HEB) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.


List of Tables 4
List of Figures 4
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Hemispherx Biopharma Plans to Raise up to USD75 Million in Public Offering of Securities 10
Hemispherx Biopharma to Raise USD2.6 Million in Private Placement of Shares 11
Hemispherx Biopharma to Raise USD0.5 Million in Private Placement of Shares 12
Hemispherx Biopharma Plans to Raise USD1.6 Million in Public Offering of Shares 13
Hemispherx Biopharma Inc - Key Competitors 14
Hemispherx Biopharma Inc - Key Employees 15
Hemispherx Biopharma Inc - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 15, 2018: Hemispherx announces six months ended June 30, 2018 financial results 17
May 16, 2018: Hemispherx Biopharma Reports First Quarter 2018 Financial Results and Provides Business Update 18
Apr 02, 2018: Hemispherx Biopharma Announced Financial Results for the Year Ended December 31, 2017 19
Nov 15, 2017: Hemispherx Biopharma Announces Corporate Progress and Financial Results for the Nine Months Ended September 30, 2017 20
Product News 21
May 14, 2018: Hemispherx to Present at the 4th Annual Immuno-Oncology: BD&L and Investment Forum 21
Aug 04, 2017: Hemispherx Encouraged by Cytokine Biomarker Discovery Which May Lead to a Diagnostic for Chronic Fatigue Syndrome 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List Of Tables


Hemispherx Biopharma Inc, Medical Equipment, Key Facts, 2017 2
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Deals By Market, 2012 to YTD 2018 8
Hemispherx Biopharma Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Hemispherx Biopharma Plans to Raise up to USD75 Million in Public Offering of Securities 10
Hemispherx Biopharma to Raise USD2.6 Million in Private Placement of Shares 11
Hemispherx Biopharma to Raise USD0.5 Million in Private Placement of Shares 12
Hemispherx Biopharma Plans to Raise USD1.6 Million in Public Offering of Shares 13
Hemispherx Biopharma Inc, Key Competitors 14
Hemispherx Biopharma Inc, Key Employees 15
Hemispherx Biopharma Inc, Other Locations 16
Hemispherx Biopharma Inc, Subsidiaries 16

List Of Figures


Hemispherx Biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Hemispherx Biopharma Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Hemispherx Biopharma Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Hemispherx Biopharma Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Hemispherx Biopharma Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

Hemispherx Biopharma Inc (HEB) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the

USD 250 View Report

Hemispherx Biopharma Inc (HEB) - Medical Equipment - Deals and Alliances Profile

Hemispherx Biopharma Inc (Hemispherx) is a biopharmaceutical company, which develops, manufactures and commercializes drug therapies for the treatments of viral and immune based chronic disorders. It offers products for the

USD 250 View Report

Principia Biopharma Inc (PRNB) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. The company, through its proprietary

USD 250 View Report

Sutro Biopharma Inc (STRO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Sutro Biopharma Inc (Sutro Biopharma), formerly Fundamental Applied Biology Inc, discovers, develops and manufactures novel cancer medicines which include antibody-drug conjugates (ADCs), bispecific antibodies, and antibody-based therapeutics targeting immuno-oncology pathways.

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available